https://www.marketscreener.com/quote/stock/GRINDEKS-15380176/news/Grindeks-Completes-Phase-1-Clinical-Study-of-its-New-Investigational-Medicinal-Product-Methyl-GBB-33960001/?utm_source=telegram&utm_medium=social&utm_campaign=share